as on March 4, 2026 at 6:04 am IST
Day's High
2.50%
Upside
52 Week's Low
52 Week's High
17.85%
Downside
177.50%
Upside
Check Bioline Rx Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$15.2M
EPS (TTM)
-0.795
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0.2
Return On Equity TTM
-45.94%
Compare market cap, revenue, PE, and other key metrics of Bioline Rx Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $15.2M | -97.53% | NA | -45.34% | |
| BUY | $126.2B | 133.18% | 32.47 | 32.94% | |
| BUY | $44.2B | 125.24% | 142.88 | 8.45% | |
| NA | $35.1B | NA | 621.55 | 5.37% | |
| BUY | $82.6B | 77.02% | 18.83 | 31.41% |
The Bioline Rx Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bioline Rx Ltd investment value today
Current value as on today
₹94,112
Returns
Returns from Bioline Rx Ltd Stock
Dollar Returns*
₹5,505 (+5.5%)
Search interest for Bioline Rx Ltd Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 148.4%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.5% return, outperforming this stock by 43.0%
Price Dip
![]()
In the last 3 years, BLRX stock has moved down by -87.9%
| Organisation | Bioline Rx Ltd |
| Headquarters | Modi?in Technology Park, Hevel Modi'in, Israel, 7177871 |
| Industry | Health Technology |
| CEO | Mr. Philip A. Serlin CPA, M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Philip A. Serlin CPA, M.B.A. | Chief Executive Officer |
Ms. Mali Zeevi CPA | Chief Financial Officer |
Dr. Ella Sorani Ph.D. | Chief Development Officer |
Mr. John Lacey | Head of Corporate Communications & Investor Relations |
Mr. Raziel Fried | Treasurer & Budgetary Control Director |
Bioline Rx Ltd share price today is $2.8 as on . Bioline Rx Ltd share today touched a day high of $2.87 and a low of $2.8.
Bioline Rx Ltd share touched a 52 week high of $7.77 on and a 52 week low of $2.3 on . Bioline Rx Ltd stock price today i.e. is trending at $2.8,which is 63.96% down from its 52 week high and 21.73% up from its 52 week low.
Bioline Rx Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Bioline Rx Ltd (BLRX) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Bioline Rx Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bioline Rx Ltd share’s latest price of $2.8 as on March 4, 2026 at 12:34 am IST, you will get 3.5714 shares of Bioline Rx Ltd. Learn more about
fractional shares .
Bioline Rx Ltd stock has given -97.53% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?